Microgenesis offers a new fertility test and treatment that restores the fertility potential of women everywhere.
Microgenesis has raised $800K in total funding. The most recent round was Convertible Note. The last funding was announced in August 2021.
Microgenesis's investors include SOSV, SOSV SF & NY (Fka IndieBio), GRID EXPONENTIAL, Happiness Capital.
Microgenesis is headquartered in San Francisco, United States.
Microgenesis offers a new fertility test and treatment that restores the fertility potential of women everywhere.
Microgenesis is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Microgenesis — Funding & Investors." VCBacked, August 5, 2021, https://www.vcbacked.co/company/microgenesis. Accessed August 15, 2026.
VCBacked. (2021). Microgenesis — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/microgenesis
{{cite web |title=Microgenesis — Funding & Investors |url=https://www.vcbacked.co/company/microgenesis |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated